Cargando…

Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

Occult breast cancer is defined by the presence of axillary metastases without an identifiable primary breast tumor. Here, we report a rare case of a male occult breast cancer with dermatomyositis. We performed a modified radical mastectomy consisting of whole breast mastectomy and axillary lymph no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Le, Zhang, Chenghua, Yang, Zhaoying, He, Miao, Zhang, Lijuan, Ezzat, Shereen, Liang, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694202/ https://www.ncbi.nlm.nih.gov/pubmed/29180879 http://dx.doi.org/10.2147/OTT.S151260

Ejemplares similares

Triple-Negative Breast Cancer with Dermatomyositis: A Case Report and Literature Review
por: Chen, Xiao, et al.
Publicado: (2022)

Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer
por: Wang, Xin-Hua, et al.
Publicado: (2022)

Dermatomyositis recalcitrant to treatment associated with occult malignancy
por: Kane, Jennifer, et al.
Publicado: (2019)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
por: Lou, Chenghua, et al.
Publicado: (2019)

A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature
por: Duan, Mingyue, et al.
Publicado: (2018)

Value of (18)F-FDG PET/CT in the detection of occult malignancy in patients with dermatomyositis
por: Li, Xiuming, et al.
Publicado: (2020)

Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
por: Xu, Ruixin, et al.
Publicado: (2017)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

Triple Negative Breast Cancer in a Male to Female Transgender Patient: A Case Report and Literature Review
por: Nehlsen, Anthony D., et al.
Publicado: (2020)

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
por: Kessler, Alaina J., et al.
Publicado: (2023)

MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
por: Zhang, Li, et al.
Publicado: (2019)

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor
por: Zhang, Le, et al.
Publicado: (2016)

A Case of Dermatomyositis with Esophageal Fistula in Whom Blind Mucosal Biopsy Detected Occult Oropharyngeal Carcinoma
por: Kabuto, Miho, et al.
Publicado: (2014)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Male triple negative axillary accessory breast cancer—a case report
por: Li, Chao, et al.
Publicado: (2022)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer
por: Lyu, Lijuan, et al.
Publicado: (2021)

Triple negative breast cancer and immunoglobulin A nephropathy: A case report and literature review
por: Jiang, Da, et al.
Publicado: (2018)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning
por: Tang, Lijuan, et al.
Publicado: (2023)

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
por: Weng, Chenghua, et al.
Publicado: (2023)

The efficacy of betulinic acid in triple-negative breast cancer
por: Weber, Daniel, et al.
Publicado: (2014)

A case report and literature review on a rare subtype of triple-negative breast cancer in children
por: Shi, Lexiang, et al.
Publicado: (2023)

Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer
por: Grigor, Emma, et al.
Publicado: (2021)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

Dermatomyositis with renal infarction: a case report and literature review
por: Zhang, Ti, et al.
Publicado: (2017)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature
por: Zhang, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fnbqcarg5vatuqsjg96t25ii5s